The drone-based crop analysis system developer secured $10.5m in a round led by Leaps by Bayer that also featured MIT-linked E14 Fund.

AST SpaceMobile, which exploits research conducted at University of Maryland, has gone public through a reverse merger with New Providence Acquisition Corp.

The Engine was among the returning investors for the Rice spinout’s series B round, having previously backed a series A in 2019.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UC Davis spinout Dysonics was acquired by Google last year, it has emerged.

Fraunhofer Society has found minimal impact from lockdowns and the pandemic on the number of spinouts its institutes were able to generate last year.

Lyell Immunopharma co-led a series A round for the gene therapy developer, which partially exploits UW research.

The cancer treatment developer, co-founded by researchers from University of Chicago, has secured funding in a round co-led by Arix Bioscience and RTW Investments.

The developer of epigenetic medicine, based on Whitehead Institute research, pulled in funding through a round led by founding investor Flagship Pioneering.

The cancer therapy developer, which is commercialising research from University of Texas, has raised series B1 and B2 financing.